Optic neuritis after COVID-19 vaccine application

Area of Science:

• Neurology
• Immunology
• Vaccinology

Background:

• The COVID-19 pandemic necessitates rapid vaccine development to mitigate severe illness and mortality.
• While generally safe, rare adverse events following COVID-19 vaccination have been documented, often mild.

Observation:

• A previously healthy 19-year-old female presented with optic neuritis.
• The onset of optic neuritis occurred one week post-vaccination with a single dose of the Ad26.COV2.S vaccine.

Findings:

• The patient experienced significant improvement in optic neuritis symptoms following management with corticosteroids.
• While a direct causal link is unconfirmed due to the absence of a specific biomarker, the temporal association is notable.

Implications:

• This case highlights a potential rare neurological adverse event associated with the Ad26.COV2.S vaccine.
• Further research into the pathogenic mechanisms underlying vaccine-induced optic neuritis is warranted.
• Understanding such rare events is crucial for vaccine safety monitoring and public health confidence.